By 24 h, fluorescence signals were primarily concentrated in the liver, kidneys, and tumor sites, with PRL@RBCM‐cRGD showing significantly enhanced tumor accumulation compared to PRL (Figure 7B,C). The gene discussed is PRL; the disease is neoplasm.